MedPath

APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

Dormant
DIN Number

02467119

Drug Class

Human

Market Date

Apr 26, 2022

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02467119
AIG Number0152509001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX23 DESVENLAFAXINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:16.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)Active
Strength: 50 MG
Monograph: DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.